One of these three genes, SNX13 (Sorting Nexin 13), was associated with both post-AI E2 levels in the M3 cohort [5] as well as sex-hormone binding globulin levels [45], which are likely to be relevant to breast cancer. Here, SNX13 is linked to breast carcinoma.